[go: up one dir, main page]

IT1396903B1 - COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD - Google Patents

COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD

Info

Publication number
IT1396903B1
IT1396903B1 ITMI2009A000445A ITMI20090445A IT1396903B1 IT 1396903 B1 IT1396903 B1 IT 1396903B1 IT MI2009A000445 A ITMI2009A000445 A IT MI2009A000445A IT MI20090445 A ITMI20090445 A IT MI20090445A IT 1396903 B1 IT1396903 B1 IT 1396903B1
Authority
IT
Italy
Prior art keywords
iron
chelants
treatment
compositions including
including antioxidants
Prior art date
Application number
ITMI2009A000445A
Other languages
Italian (it)
Inventor
Piergiorgio Anzaghi
Original Assignee
River Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by River Pharma Srl filed Critical River Pharma Srl
Priority to ITMI2009A000445A priority Critical patent/IT1396903B1/en
Publication of ITMI20090445A1 publication Critical patent/ITMI20090445A1/en
Application granted granted Critical
Publication of IT1396903B1 publication Critical patent/IT1396903B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
ITMI2009A000445A 2009-03-23 2009-03-23 COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD IT1396903B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2009A000445A IT1396903B1 (en) 2009-03-23 2009-03-23 COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A000445A IT1396903B1 (en) 2009-03-23 2009-03-23 COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD

Publications (2)

Publication Number Publication Date
ITMI20090445A1 ITMI20090445A1 (en) 2010-09-24
IT1396903B1 true IT1396903B1 (en) 2012-12-20

Family

ID=41152028

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A000445A IT1396903B1 (en) 2009-03-23 2009-03-23 COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD

Country Status (1)

Country Link
IT (1) IT1396903B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6646157B2 (en) * 1999-12-21 2003-11-11 Geltex Pharmaceuticals, Inc. Method for making HBED
US7776312B2 (en) * 2004-08-13 2010-08-17 Healthpartners Research Foundation Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
US20100108086A1 (en) * 2007-01-22 2010-05-06 Technion Research & Development Foundation Ltd Tobacco and tobacco packaging material for preventing or reducing tobacco-associated injury in the aerodigestive tract of a subject

Also Published As

Publication number Publication date
ITMI20090445A1 (en) 2010-09-24

Similar Documents

Publication Publication Date Title
ZA201200054B (en) Therapeutic compounds and compositions
SMT201500213B (en) Some triazolopirazine, their compositions and methods of use
IL240140A0 (en) Anti parasitic dihydroazole compounds and compositions comprising same
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
SI2594567T1 (en) Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
EP2515946A4 (en) NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS
SMT201400160B (en) New compositions for the treatment of cmt and related diseases
WO2011049960A9 (en) Compositions and methods for the treatment of sinonasal disorders
GB0921075D0 (en) Novel combination of the therapeutic agents
PL2433622T3 (en) Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
ZA201203002B (en) Compositions and methods for treating inflammatory disorders
SI2470166T1 (en) New compositions of 1-š2-(2,4-dimethyl-phenylsulfanyl)-phenylćpiperazine
SMT201400165B (en) Compositions and methods for the treatment of multiple sclerosis
IL215154A0 (en) Photodynamic disinfection compositions and uses thereof
GB0902429D0 (en) Compositions and their use
IL218001A0 (en) Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases
PL2498613T3 (en) Biocidal compositions and methods of use
HU0900231D0 (en) Compositions for the treatment of allergic disorders
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
IT1396903B1 (en) COMPOSITIONS INCLUDING ANTIOXIDANTS AND CHELANTS OF THE IRON AND THEIR USE FOR THE TREATMENT OF THE IRON OVERLOAD
HUP1200500A2 (en) Preventive compositions against pathogenic germs and the use thereof
GB0819446D0 (en) Treatment of inflammatory disorders
HRP20160663T1 (en) Formulation of compositions for the treatment of inflammatory conditions
GB0921929D0 (en) Compositions and methods for the treatment of influenza
IL219741A0 (en) Methods for improving the design, bioavailability, and efficacy of dsp compositions